Related Experiment Video
Updated: Oct 24, 2026

Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology
Published on: March 23, 2011
The Drug's the Same but the Range Has Changed: Revisiting Therapeutic Ranges for Older Medications
Nicholas E Heger1, Christine L H Snozek2
1Department of Pathology and Laboratory Medicine, Tufts Medical Center, 800 Washington Street Box 115, Boston, MA 02111, USA; Department of Anatomic and Clinical Pathology, Tufts University School of Medicine, 800 Washington Street Box 115, Boston, MA 02111, USA.
Abstract:
Therapeutic drug monitoring is an essential tool for optimizing pharmacotherapy and avoiding toxicity, yet for many older drugs, therapeutic ranges are derived from historical studies that may not reflect contemporary clinical practice. Changing clinical indications, greater recognition of patient-specific factors, and new pharmacokinetic data may support the need for updated ranges. This review examines methodological, clinical, and analytical challenges in defining and updating therapeutic ranges, including heterogeneous study designs, variable clinical endpoints, drug interactions, and interassay variability. Using vancomycin, digoxin, lithium, and first-generation antiepileptic drugs as examples, we highlight how therapeutic targets have evolved despite incomplete adoption by laboratories.
Related Concept Videos
Drug Dosing: Geriatric Patients
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Dosage Regimen: Individualization